HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roland Seifert Selected Research

Anaphylaxis (Anaphylactic Shock)

1/2021Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE).
1/2021Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis.
1/2014Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roland Seifert Research Topics

Disease

10Asthma (Bronchial Asthma)
01/2021 - 11/2009
10Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
06/2016 - 08/2002
9Lymphoma (Lymphomas)
01/2020 - 09/2002
7Neuroblastoma
09/2014 - 06/2005
6Infections
10/2023 - 08/2011
6Colitis
04/2020 - 09/2014
6Anthrax
07/2015 - 03/2009
5Heart Failure
01/2016 - 04/2007
4Inflammation (Inflammations)
07/2021 - 01/2010
3Hypersensitivity (Allergy)
01/2021 - 11/2009
3Anaphylaxis (Anaphylactic Shock)
01/2021 - 01/2014
3Neoplasms (Cancer)
01/2020 - 04/2007
3Eosinophilia
04/2015 - 01/2012
3Whooping Cough (Pertussis)
04/2012 - 05/2004
2Vitamin A Deficiency
03/2024 - 12/2022
2Hypertension (High Blood Pressure)
12/2023 - 07/2015
2Psychotic Disorders (Schizoaffective Disorder)
12/2023 - 04/2007
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023 - 09/2014
2Pain (Aches)
10/2023 - 03/2011
2Virus Diseases (Viral Diseases)
10/2023 - 01/2021
2Cardiomyopathies (Cardiomyopathy)
12/2022 - 06/2009
2Obesity
12/2022 - 12/2015
2Fibrosis (Cirrhosis)
01/2022 - 07/2021
2Atopic Dermatitis (Atopic Eczema)
05/2011 - 04/2011
2Pruritus (Itching)
05/2011 - 04/2011
1Colonic Neoplasms (Colon Cancer)
12/2023
1Alopecia (Baldness)
10/2023
1Type 2 Diabetes Mellitus (MODY)
12/2022
1Diabetic Cardiomyopathies
12/2022
1Mitochondrial Diseases (Mitochondrial Disease)
12/2022
1Poisoning
11/2022
1Hypothermia
01/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022
1Kidney Diseases (Kidney Disease)
01/2022
1Cardiogenic Shock
01/2022
1Communicable Diseases (Infectious Diseases)
11/2021
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
07/2021
1Carcinogenesis
04/2020

Drug/Important Bio-Agent (IBA)

15Histamine (Histamine Dihydrochloride)FDA Link
12/2023 - 11/2009
15Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2016 - 04/2003
8purineIBA
01/2016 - 08/2002
7cyclic 3',5'-uridine monophosphateIBA
10/2023 - 05/2014
6Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
11/2015 - 06/2005
6edema factorIBA
07/2015 - 05/2004
5Histamine Receptors (Histamine Receptor)IBA
04/2020 - 01/2014
5sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2020 - 11/2015
5Histamine H4 ReceptorsIBA
01/2020 - 01/2010
5Proteins (Proteins, Gene)FDA Link
01/2018 - 09/2002
5TransferasesIBA
07/2012 - 06/2005
5HypoxanthineIBA
07/2012 - 06/2005
5GTP-Binding Proteins (G-Protein)IBA
08/2011 - 08/2002
4Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 03/2009
4CytokinesIBA
07/2021 - 11/2015
4Dextrans (Dextran)FDA Link
04/2020 - 11/2015
4Cyclic NucleotidesIBA
01/2018 - 12/2014
4EnzymesIBA
11/2015 - 06/2005
41- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
11/2015 - 11/2009
4Calmodulin (Calcium-Dependent Activator Protein)IBA
07/2015 - 09/2007
4LigandsIBA
09/2014 - 11/2009
2Vitamin A (Retinol)FDA LinkGeneric
03/2024 - 12/2022
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
10/2023 - 01/2021
2RNA (Ribonucleic Acid)IBA
12/2022 - 01/2022
2Antiviral Agents (Antivirals)IBA
01/2021 - 02/2014
24'-N,N-dimethylamino-4-aminoazobenzeneIBA
01/2021 - 01/2014
2NucleosidesIBA
01/2020 - 06/2007
2OvalbuminIBA
04/2015 - 01/2012
2AllergensIBA
11/2013 - 01/2012
2Immunoglobulin E (IgE)IBA
11/2013 - 01/2012
2ColforsinIBA
07/2012 - 04/2003
2ExotoxinsIBA
01/2012 - 03/2009
2Pyrilamine (Mepyramine)FDA Link
01/2012 - 11/2009
2Pyrimidine NucleotidesIBA
08/2009 - 03/2009
2Nucleoside-TriphosphataseIBA
06/2007 - 06/2005
2Guanosine Triphosphate (GTP)IBA
01/2006 - 04/2003
2Guanosine 5'-O-(3-Thiotriphosphate)IBA
12/2003 - 04/2003
1Reserpine (Serpasil)FDA Link
12/2023
1Loratadine (Alavert)FDA Link
10/2023
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2023
1Cetirizine (Zyrtec)FDA LinkGeneric
10/2023
1lecithin-retinol acyltransferaseIBA
12/2022
1PoisonsIBA
11/2022
1OctopamineIBA
01/2022
1BAY 58-2667IBA
01/2022
1Streptozocin (Streptozotocin)FDA Link
01/2022
1Thrombospondin 1IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1CreatinineIBA
01/2022
1CollagenIBA
07/2021
12- (2- Chloro- 4- (methylsulfonyl)- 3- ((2,2,2- trifluoroethoxy)methyl)benzoyl)- 1,3- cyclohexanedione (BAY 747)IBA
07/2021
1InterferonsIBA
01/2021
1bis(3',5')-cyclic diguanylic acidIBA
01/2021
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2020
1CarcinogensIBA
04/2020
1AzoxymethaneIBA
04/2020
1GuanosineIBA
01/2020
1Interleukin-2 (IL2)IBA
01/2020

Therapy/Procedure

7Therapeutics
01/2022 - 01/2014
2Critical Care (Surgical Intensive Care)
01/2021 - 01/2014